AzTrials
AzTrials

LeadershipEVILEAD-CHNCT05244499

Evidence-based Leadership in Nurse Leaders-CH

A study testing Evidence-based leadership training and Conventional training in people with Leadership, run by University of Turku at 2 sites in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study protocol describes a randomised feasibility trial that will evaluate the feasibility and preliminary effectiveness of the training course to improve evidence-based leadership competencies among nurse leaders working in hospitals in China. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Leadership
What is being tested?
Evidence-based leadership training and Conventional training
Could I receive a placebo?
No, everyone receives an active treatment
How many people
119 participants
Where
2 sitesChina
Study dates
13 Jul 2022to 30 May 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Official managerial role in the study organisation (hospital, clinic, ward level), which give them an authority to act as a nurse leader and monitor, develop and evaluate the care
  • Being in full time or part time position
  • All sex
  • Aged up to 65 years
  • Working in the study sites at the time of the recruitment
  • Ability to read and write simple Chinese language
  • Willingness to join the study based on their own free will
  • Informed consent obtained

Who cannot join

  • Non-nursing professionals in leadership position (e.g. physician, psychologist, pharmacist, dietician/nutritionist, dentist, physiotherapist, radiation therapist, paramedic, occupational therapist, social worker, or disability worker)
  • Speaking only other languages than simple Chinese
  • Out of duty during the recruitment period for family leave, long term sick leave, study leave or any other reason

Trial locations and contacts

2 sites in 1 country.

China2 sites

  • Hunan Tumor Hospital

    Changsha, Hunan, 410013

  • Xiangya Hospital

    Changsha, Hunan, 410013

Other trials in China

About this study

Official title: Online Training to Improve Evidence-based Leadership Competencies Among Nurse Leaders in China: Study Protocol for a Randomised Feasibility Trial (EVILEAD-CH)

This study protocol describes a randomised feasibility trial that will evaluate the feasibility and preliminary effectiveness of the training course to improve evidence-based leadership competencies among nurse leaders working in hospitals in China.

Read the detailed description

This study will include a 6-months training intervention for nurse leaders working in hospital settings in China. About 150 nurse leaders fulfilling the eligibility criteria will be randomly allocated (1:1) to participate in the online training course about evidence-based leadership or conventional leadership training course (reading material only)

Conditions
Leadership
Being tested
Evidence-based leadership training, Conventional training
Keywords
feasibility, randomised controlled trial, training

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Evidence-based leadership trainingOther

    7-modules online training over six months mentored by tutors. Independent familiarisation of reading material, peer-group discussions, self-reflection, assignments, tutor's feedback.

  • Conventional trainingOther

    7-modules online training over six months. Independent reading only.

Study groups in NCT05244499
Study groupRoleWhat they receive
Evidence-based leadership trainingExperimentalThe training course will take 6 months. It is divided into seven online modules. Participants join the course based on pre-structured schedule. The progress of the training course will follow specific steps to improve participants' evidence-based leadership competencies. First, each participant identifies one leadership problem on daily practice. Second, organisational data will be collected and analysed to increase the understanding of the key problem. Third, scientific literature will be searched, identified and critically appraised to find solutions. Fourth, the views of stakeholders (patients, clinicians, family members, etc.) are considered together with ethical implications. And last, all sources of information are critically appraised, new solution will be designed and implemented into the practice, and evaluated in real world context. Each module includes specific learning material. Trained tutors are responsible for mentoring each module.
Receives: Other: Evidence-based leadership training
Conventional trainingActive comparatorThe participants will join a training course with the same structure, topics, and timing as the experimental group. However, training in this group is based on independent learning methods. The participants have access to the separate learning platform, which includes reading material to be read independently. No group discussions with peers, self-reflection, assignments, or support from tutors will be offered.
Receives: Other: Conventional training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Acceptability of the intervention

    The degree of execution (success and failure of execution) of the intervention protocol by calculating the number of logins for each module and all participants

    Measured: 6 months

  2. Adherence in the course

    Adherence in the course by calculating the number of returned course tasks out of all possible tasks

    Measured: 6 months

  3. Adherence in the course tasks

    Adherence in the course by calculating the number of returned course tasks by each participant

    Measured: 6 months

  4. Drop-out rate

    The drop-out rate calculated by the number of participants who left the study early (no follow-up data)

    Measured: 6 months

Secondary outcomes (9)

  1. Acceptability in recruitment

    The number of nurse leaders who accepted (or refused) the invitation to participate in the research study

    Measured: Baseline

  2. Feasibility of the eligibility criteria

    The number of nurse leaders who fulfilled eligibility criteria

    Measured: Baseline

  3. Feasibility of the outcome instruments for measuring the potential effectiveness of the online course

    The number of missing variables of each returned instrument

    Measured: Baseline and 6 months

  4. Leadership skills (Multifactor Leadership Questionnaire [MLQ])

    Multifactor Leadership Questionnaire (MLQ)leadership skills

    Measured: Baseline and 6 months

  5. Evidence-based practice, knowledge, and attitudes (Evidence Based Practice Questionnaire [EBPQ])

    Evidence-Based Practice Questionnaire (EBPQ)

    Measured: Baseline and 6 months

  6. Self-efficacy (General Self-Efficacy Scale [GSE])

    General Self-Efficacy Scale (GSE)

    Measured: Baseline and 6 months

  7. Self-esteem (Rosenberg Self-Esteem Scale [RSE])

    Rosenberg Self-Esteem Scale (RSE)

    Measured: Baseline and 6 months

  8. Intention to leave (questionnaire)

    Three-item questionnaire

    Measured: Baseline and 6 months

  9. Course feedback (questionnaire)

    Eight-item questionnaire

    Measured: Baseline and 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Feb 2022
  2. Study start13 Jul 2022
  3. Primary completion30 May 2023
  4. Study completion30 May 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Model description
A single-blind, individually randomised, two-arm parallel-group controlled feasibility trial design will be used.
Masking
Double blind
Who is masked
Participant, Care provider
Enrolment
119 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05244499
Sponsor's protocol ID
CHEvidence
Acronym
EVILEAD-CH
Status last verified
Nov 2023
First submitted
7 Feb 2022
Last updated
29 Nov 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: According to the ethical reasons

Publications

  • Hu S, Liu S, Hu H, Hu J, Shumaila B, Chen W, Yang Q, Liu G, Valimaki M, Li X. Nurse leaders' perspectives on a feasibility randomized controlled trial evaluating an online training program to improve evidence-based leadership: a qualitative descriptive study. BMC Nurs. 2026 May 23;25(1):599. doi: 10.1186/s12912-026-04779-6.

    PubMed 42177553

  • Hu S, Chen W, Satamo M, Loyttyniemi E, Yang M, Liu G, Chen J, Tang Y, Varpula J, Li X, Valimaki M. Online training to improve evidence-based leadership competencies among nurse leaders in China: a feasibility randomised controlled trial. BMJ Open. 2024 Nov 7;14(11):e088386. doi: 10.1136/bmjopen-2024-088386.

    PubMed 39510773

  • Valimaki MA, Kirsi H, Yang M, Lantta T, Varpula J, Liu G, Tang Y, Chen W, Hu S, Chen J, Loyttyniemi E, Li X. Online training to improve evidence-based leadership competencies among nurse leaders in Finland and China: study protocols for two randomised feasibility trials. BMJ Open. 2023 Aug 14;13(8):e067306. doi: 10.1136/bmjopen-2022-067306.

    PubMed 37580090

Questions about this trial

What is this clinical trial studying?

A study testing Evidence-based leadership training and Conventional training in people with Leadership, run by University of Turku at 2 sites in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 Nov 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Acceptability of the intervention (time frame: 6 months). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05244499, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Nov 2023.

AzTrials uses cookies for analytics and advertising. You can accept or reject them; the site works either way. Privacy Policy.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in